Latest news
FDA approves Moderna’s mRNA flu vaccine - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 11:10:45 GMTModerna reports stronger outlook as pipeline advances and losses narrow - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 09:31:14 GMTModerna Narrows 2Q Loss, Says New Norovirus Vaccine Didn't Meet Expectations in Late-Stage Trial - MoomooMoomoo · Fri, 31 Jul 2026 11:30:00 GMTModerna Says Norovirus Vaccine Didn’t Meet Statistical Criteria for Early Success in Trial - WSJWSJ · Fri, 31 Jul 2026 07:00:00 GMTMRNA: Q2 2026 revenue up 2% YoY, net loss narrows, with strong liquidity and growth outlook - TradingViewTradingView · Fri, 31 Jul 2026 07:00:00 GMT